Vocal fold augmentation with injectable polycaprolactone microspheres/pluronic F127 hydrogel: Long-term in vivo study for the treatment of glottal insufficiency

Seong Keun Kwon, Hee Bok Kim, Jae-Jun Song, Chang Gun Cho, Seok Won Park, Jong Sun Choi, Junsun Ryu, Se Heang Oh, Jin Ho Lee

Research output: Contribution to journalArticle

18 Citations (Scopus)

Abstract

There is increasing demand for reconstruction of glottal insufficiency. Several injection materials have been examined for this purpose, but all had limitations, such as poor long-term durability, migration from the injection site, inflammation, granuloma formation, and interference with vocal fold vibration due to viscoelastic mismatch. Here, we developed a novel injection material, consisting of polycaprolactone (PCL) microspheres, which exhibits better viscoelasticity than conventional materials, and Pluronic F127 carrier, which decreases the migration of the injection materials. The material was injected into rabbits with glottal insufficiency and compared with the FDA-approved injection material, calcium hydroxylapatite (CaHA). Endoscopic and histological examinations indicated that PCL/Pluronic F127 remained at the injection site with no inflammatory response or granuloma formation, whereas CaHA leaked out and migrated from the injection site. Therefore, vocal fold augmentation was almost completely retained during the 12-month follow-up period in this study. Moreover, induced phonation and high-speed recording of vocal fold vibration showed decreased vocal fold gap area in the PCL/Pluronic F127 group. Our newly developed injection material, PCL/Pluronic F127, permits efficient augmentation of paralyzed vocal fold without complications, a concept that can be applied clinically, as demonstrated by the successful long-term follow-up.

Original languageEnglish
Article numbere85512
JournalPLoS One
Volume9
Issue number1
DOIs
Publication statusPublished - 2014 Jan 22
Externally publishedYes

Fingerprint

UCON 50-HB-5100
Poloxamer
Vocal Cords
Hydrogel
hydrocolloids
in vivo studies
Microspheres
Injections
injection site
injection
granuloma
Durapatite
vibration
Therapeutics
Vibration
Granuloma
inflammation
Calcium
calcium
viscoelasticity

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)
  • Agricultural and Biological Sciences(all)

Cite this

Vocal fold augmentation with injectable polycaprolactone microspheres/pluronic F127 hydrogel : Long-term in vivo study for the treatment of glottal insufficiency. / Kwon, Seong Keun; Kim, Hee Bok; Song, Jae-Jun; Cho, Chang Gun; Park, Seok Won; Choi, Jong Sun; Ryu, Junsun; Oh, Se Heang; Lee, Jin Ho.

In: PLoS One, Vol. 9, No. 1, e85512, 22.01.2014.

Research output: Contribution to journalArticle

Kwon, Seong Keun ; Kim, Hee Bok ; Song, Jae-Jun ; Cho, Chang Gun ; Park, Seok Won ; Choi, Jong Sun ; Ryu, Junsun ; Oh, Se Heang ; Lee, Jin Ho. / Vocal fold augmentation with injectable polycaprolactone microspheres/pluronic F127 hydrogel : Long-term in vivo study for the treatment of glottal insufficiency. In: PLoS One. 2014 ; Vol. 9, No. 1.
@article{c210576d4f5d486db654706a0d67c1e8,
title = "Vocal fold augmentation with injectable polycaprolactone microspheres/pluronic F127 hydrogel: Long-term in vivo study for the treatment of glottal insufficiency",
abstract = "There is increasing demand for reconstruction of glottal insufficiency. Several injection materials have been examined for this purpose, but all had limitations, such as poor long-term durability, migration from the injection site, inflammation, granuloma formation, and interference with vocal fold vibration due to viscoelastic mismatch. Here, we developed a novel injection material, consisting of polycaprolactone (PCL) microspheres, which exhibits better viscoelasticity than conventional materials, and Pluronic F127 carrier, which decreases the migration of the injection materials. The material was injected into rabbits with glottal insufficiency and compared with the FDA-approved injection material, calcium hydroxylapatite (CaHA). Endoscopic and histological examinations indicated that PCL/Pluronic F127 remained at the injection site with no inflammatory response or granuloma formation, whereas CaHA leaked out and migrated from the injection site. Therefore, vocal fold augmentation was almost completely retained during the 12-month follow-up period in this study. Moreover, induced phonation and high-speed recording of vocal fold vibration showed decreased vocal fold gap area in the PCL/Pluronic F127 group. Our newly developed injection material, PCL/Pluronic F127, permits efficient augmentation of paralyzed vocal fold without complications, a concept that can be applied clinically, as demonstrated by the successful long-term follow-up.",
author = "Kwon, {Seong Keun} and Kim, {Hee Bok} and Jae-Jun Song and Cho, {Chang Gun} and Park, {Seok Won} and Choi, {Jong Sun} and Junsun Ryu and Oh, {Se Heang} and Lee, {Jin Ho}",
year = "2014",
month = "1",
day = "22",
doi = "10.1371/journal.pone.0085512",
language = "English",
volume = "9",
journal = "PLoS One",
issn = "1932-6203",
publisher = "Public Library of Science",
number = "1",

}

TY - JOUR

T1 - Vocal fold augmentation with injectable polycaprolactone microspheres/pluronic F127 hydrogel

T2 - Long-term in vivo study for the treatment of glottal insufficiency

AU - Kwon, Seong Keun

AU - Kim, Hee Bok

AU - Song, Jae-Jun

AU - Cho, Chang Gun

AU - Park, Seok Won

AU - Choi, Jong Sun

AU - Ryu, Junsun

AU - Oh, Se Heang

AU - Lee, Jin Ho

PY - 2014/1/22

Y1 - 2014/1/22

N2 - There is increasing demand for reconstruction of glottal insufficiency. Several injection materials have been examined for this purpose, but all had limitations, such as poor long-term durability, migration from the injection site, inflammation, granuloma formation, and interference with vocal fold vibration due to viscoelastic mismatch. Here, we developed a novel injection material, consisting of polycaprolactone (PCL) microspheres, which exhibits better viscoelasticity than conventional materials, and Pluronic F127 carrier, which decreases the migration of the injection materials. The material was injected into rabbits with glottal insufficiency and compared with the FDA-approved injection material, calcium hydroxylapatite (CaHA). Endoscopic and histological examinations indicated that PCL/Pluronic F127 remained at the injection site with no inflammatory response or granuloma formation, whereas CaHA leaked out and migrated from the injection site. Therefore, vocal fold augmentation was almost completely retained during the 12-month follow-up period in this study. Moreover, induced phonation and high-speed recording of vocal fold vibration showed decreased vocal fold gap area in the PCL/Pluronic F127 group. Our newly developed injection material, PCL/Pluronic F127, permits efficient augmentation of paralyzed vocal fold without complications, a concept that can be applied clinically, as demonstrated by the successful long-term follow-up.

AB - There is increasing demand for reconstruction of glottal insufficiency. Several injection materials have been examined for this purpose, but all had limitations, such as poor long-term durability, migration from the injection site, inflammation, granuloma formation, and interference with vocal fold vibration due to viscoelastic mismatch. Here, we developed a novel injection material, consisting of polycaprolactone (PCL) microspheres, which exhibits better viscoelasticity than conventional materials, and Pluronic F127 carrier, which decreases the migration of the injection materials. The material was injected into rabbits with glottal insufficiency and compared with the FDA-approved injection material, calcium hydroxylapatite (CaHA). Endoscopic and histological examinations indicated that PCL/Pluronic F127 remained at the injection site with no inflammatory response or granuloma formation, whereas CaHA leaked out and migrated from the injection site. Therefore, vocal fold augmentation was almost completely retained during the 12-month follow-up period in this study. Moreover, induced phonation and high-speed recording of vocal fold vibration showed decreased vocal fold gap area in the PCL/Pluronic F127 group. Our newly developed injection material, PCL/Pluronic F127, permits efficient augmentation of paralyzed vocal fold without complications, a concept that can be applied clinically, as demonstrated by the successful long-term follow-up.

UR - http://www.scopus.com/inward/record.url?scp=84899881175&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84899881175&partnerID=8YFLogxK

U2 - 10.1371/journal.pone.0085512

DO - 10.1371/journal.pone.0085512

M3 - Article

C2 - 24465582

AN - SCOPUS:84899881175

VL - 9

JO - PLoS One

JF - PLoS One

SN - 1932-6203

IS - 1

M1 - e85512

ER -